Advertisement
Advertisement

HEPA

HEPA logo

Hepion Pharmaceuticals, Inc. Common Stock

0.188
USD
-0.02
-9.57%
Feb 21, 15:59 UTC -5
Closed
exchange

After-Market

0.167

-0.02
-11.17%

Hepion Pharmaceuticals, Inc. Common Stock Profile

About

Hepion Pharmaceuticals Inc. is a clinical stage biopharmaceutical company. It is focused on the development of targeted therapies for liver disease arising from non-alcoholic steatohepatitis and chronic hepatitis virus infection. The Company's lead drug candidate CRV431, reduces liver fibrosis and hepatocellular carcinoma tumor burden in experimental models of NASH. Hepion Pharmaceuticals Inc., formerly known as ContraVir Pharmaceuticals Inc., is based in Edison, New Jersey.

Info & Links

CEO

John Cavan

Headquarters

399 THORNALL STREET,FIRST FLOOR
EDISON, NJ 08837, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.hepionpharma.com

Auditor

GRASSI & CO., CPAs, P.C.

Share holders

344

Employees

22

Hepion Pharmaceuticals, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

1.16M

Enterprise Value

1.77M

Enterprise Value/EBITDA(ttm)

-0.07

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-812.56%

Return on Invested Capital(ttm)

896.45%

Return on Assets(ttm)

-207.31%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-24.85M

Net Income Available to Common(ttm)

-22.70M

Diluted EPS(ttm)

-4.38

Share Statistics

Beta (5Y Monthly)

1.65

52-Week Change

-91.72%

S&P 500 52-Week Change

18.16%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

6.96M

Dividend Yield

0.00%

Float4

6.63M

% Held by Insiders

4.70%

% Held by Institutions

17.24%

Balance Sheet

Total Cash(mrq)

1.50M

Total Cash Per Share(mrq)

0.22

Total Debt(mrq)

2.11M

Total Debt/Equity(mrq)

-517.78%

Current Ratio(mrq)

1.30%

Quick Ratio(mrq)

1.30%

Book Value Per Share(mrq)

-0.06

Cash Flow

Operating Cash Flow Per Share(ytd)

-2.54

Free Cash Flow(ytd)

-17.06M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement